Cargando…

Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis

Detalles Bibliográficos
Autores principales:	Zhao, Li-Min, Chen, Xie-Hui, Qiu, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785330/ https://www.ncbi.nlm.nih.gov/pubmed/35082762 http://dx.doi.org/10.3389/fendo.2021.825100

Ejemplares similares

Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Kan, Chengxia, et al.
Publicado: (2021)

Commentary: Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Qiu, Mei, et al.
Publicado: (2021)

The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
por: Chen, Yidan, et al.
Publicado: (2022)

Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis
por: Wang, Yuhan, et al.
Publicado: (2022)

Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysis
por: Goyat, Rashmi, et al.
Publicado: (2017)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank
por: Xue, Pei, et al.
Publicado: (2021)

Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis
por: Li, Gangfeng, et al.
Publicado: (2023)

Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis
por: Jia, Yongliang, et al.
Publicado: (2015)

Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy
por: Markelic, Milica, et al.
Publicado: (2023)

Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study
por: Zerovnik, Spela, et al.
Publicado: (2021)

General Commentary: Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study
por: Muche, Burkhard
Publicado: (2022)

Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
por: Deng, Jiawen, et al.
Publicado: (2020)

Commentary: Is there a role for diabetes-specific nutrition formulas as meal replacements in type 2 diabetes?
por: Glenn, Andrea J., et al.
Publicado: (2023)

ABCA1 69C>T Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Systematic Review and Updated Meta-Analysis
por: Yoon, Ha Young, et al.
Publicado: (2021)

Effect of passive smoking exposure on risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies
por: Qin, Guo-Qiang, et al.
Publicado: (2023)

Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol
por: Wang, Xianzhe, et al.
Publicado: (2019)

Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis
por: Zhang, Yu-Sheng, et al.
Publicado: (2021)

Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR”
por: Zhao, Li-Min, et al.
Publicado: (2021)

Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies
por: Wang, Yining, et al.
Publicado: (2023)

Microbiota: A potential orchestrator of antidiabetic therapy
por: Liu, Bingyao, et al.
Publicado: (2023)

Efficacy of Various Antidiabetic Agents as Add-On Treatments to Metformin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2012)

Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
por: Long, Caiyi, et al.
Publicado: (2022)

Commentary: Intestinal barrier function and immune homeostasis are missing links in obesity and type 2 diabetes development
por: Wang, Yi-feng, et al.
Publicado: (2022)

Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study
por: Wang, Zhaonan, et al.
Publicado: (2022)

Commentary: Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?
por: Kameda, Yusuke
Publicado: (2023)

Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis
por: Chen, Shi, et al.
Publicado: (2023)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
por: Hu, Yao, et al.
Publicado: (2020)

Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis
por: Adeloye, Davies, et al.
Publicado: (2017)

Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review
por: Zhang, Xiaoying, et al.
Publicado: (2022)

Diabetes health coach in individuals with type 2 diabetes: A systematic review and meta analysis of quadruple aim outcomes
por: Racey, Megan, et al.
Publicado: (2022)

The efficacy and safety of evogliptin for type 2 diabetes mellitus: A systematic review and meta-analysis
por: Tang, Qizhi, et al.
Publicado: (2022)

Commentary: Early Clinical Indicators of Addison's Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study
por: Brož, Jan, et al.
Publicado: (2019)

Association between adipocytokines and diabetic retinopathy: a systematic review and meta-analysis
por: Jiang, Yanhua, et al.
Publicado: (2023)

Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Shi, Shaomin, et al.
Publicado: (2022)

Progression to type 2 diabetes mellitus after gestational diabetes mellitus diagnosed by IADPSG criteria: Systematic review and meta-analysis
por: Juan, Juan, et al.
Publicado: (2022)

Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis
por: Ma, Hua, et al.
Publicado: (2021)

Association Between Enterovirus Infection and Type 1 Diabetes Risk: A Meta-Analysis of 38 Case-Control Studies
por: Wang, Kan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_trm6vrqev867ml0i2j4qoe43jc